Markets & Economy Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study September 2, 2026 · 3:48 pm 1 sources Image: Yahoo Finance ad slot · in-content video 16:9 Coverage More coverageCan-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer StudyYahoo Finance · September 2, 2026 15:48